Related Experiment Video

Updated: Jun 2, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

[Cycloferon efficacy in viral and bacterial diseases of children (clinical review)]

M G Romantsov, L G Goryacheva, M K Bekhtereva

    Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
    |May 18, 2011
    PubMed

    Insights

    Cycloferon, an interferon inducer, demonstrates significant efficacy in treating various childhood illnesses, including infections and asthma. It also prevents post-vaccination complications and corrects gut dysbiosis in children.

    Area of Science:

    • Immunology
    • Pediatrics
    • Pharmacology

    Background:

    • Cycloferon is an interferon inducer with immunomodulatory properties.
    • Its therapeutic efficacy has been documented in various clinical settings.

    Purpose of the Study:

    • To review the pharmacotherapeutic efficacy of Cycloferon in pediatric patients.
    • To evaluate its use in treating socially significant childhood diseases and post-vaccination complications.

    Main Methods:

    • Literature data review and analysis of clinical findings.
    • Assessment of Cycloferon's effects in various pediatric conditions, including infections, asthma, allergies, and surgical pathologies.
    • Evaluation of its impact on autoimmune processes and gut microflora.

    Main Results:

    • Cycloferon effectively treats viral respiratory infections, bronchial asthma, and allergic conditions with immune disturbances.
    • It inhibits autoimmune processes, preventing post-vaccination complications in frequently ill children.
    • The drug is effective in treating gastrointestinal and intestinal infections (viral and bacterial), correcting intestinal dysbiosis in 95% of cases.
    • It reduces postoperative complications in appendicular peritonitis and corrects immune disturbances in chronic viral hepatitis B and C.

    Conclusions:

    • Cycloferon is a safe and effective drug for a wide range of pediatric conditions.
    • Its immunomodulatory and antiviral properties make it valuable in treating infections, allergies, and in post-vaccination care.
    • Recommended for correcting intestinal dysbiosis and as part of complex therapy for surgical and chronic viral infections in children.

    Related Concept Videos

    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Lytic Cycle of Bacteriophages01:30

    Lytic Cycle of Bacteriophages

    Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...